Session Details
[26PO10-am1]Drug delivery system in oncotherapy-2/Genetic drug delivery system/Testing, property and stability of medicinal formulation
Sat. Mar 26, 2022 9:00 AM - 10:40 AM JST
Sat. Mar 26, 2022 12:00 AM - 1:40 AM UTC
Sat. Mar 26, 2022 12:00 AM - 1:40 AM UTC
[Room PO10] Lounge in front of Room D Bldg. 1: 4F
【説明時間】9:15～10:25
[26PO10-am1-01]Plant-derived exosome like nanovesicles show the potential for colorectal cancer prevention as a novel component of food.
○Hideki Takakura1,2, keisuke Oda1, Toshimasa Nakao2, Takumi Narita2, Mano Horinaka2, Yukako Nakao-Ise2, Tetsusi Yamamoto3, Yosuke Iizumi2, Motoki Watanabe2, Yoshihiro Sowa2, Toshiyuki Sakai2, Michihiro Mutoh2, Nobuhiro Mori1 (1. Faculty of Pharmaceutical Sciences, Hiroshima International University, 2. Kyoto Prefectural University of Medicine, 3. Faculty of Pharmacy, Kindai University)
[26PO10-am1-02]Enhancement of tumor disposition of PEG-liposome by pre-administration of oncolytic reovirus in tumor-bearing mice
○FUMINORI SAKURAI1, Seiya Hirata1, Maho Eguchi1, Ikuho Ishigami1, Mika Hosokawa2, Ken-ichi Ogawara2, Hiroyuki Mizuguchi1,3,4,5 (1. Grad.Sch.Pharm.Sci., Osaka Univ., 2. Kobe Pharm. Univ., 3. MEI Center, Osaka Univ., 4. OTRI, Osaka Univ., 5. NIBIOHN)
[26PO10-am1-03]Preparation of liposomes co-encapsulating doxorubicin and mifepristone for the treatment of drug-resistant cancer
○Kumi Kawano1, Yuta Nakagawa1, Ayami Furuya1, Yuri Matsuda1, Chisato Kimura1, Kotono Yamaguchi1, Sakura Wakabayashi1, Kotone Taniguchi2, Keiichi Ozaki2, Yoshiyuki Hattori1 (1. Hoshi University, 2. Faculty of Pharmaceutical Sciences, Doshisha Women's College of Liberal Arts)
[26PO10-am1-04]Development of novel functional lipids having a piperazine moiety
○Sae Asayama1, Ayano Yokouchi1, Yuki Inoue1, Koji Tomita1, Noriyuki Maeda1, Naoto Oku3, Tomohiro Asai2 (1. Nippon Fine Chemical Co., Ltd. , 2. Univ. Shizuoka, Sch. Pharm. Sci., 3. Fac. of Pharma-Science, Teikyo Univ.,)
[26PO10-am1-05]Development of novel Charge-Reversible lipid having a ceramide skeleton
○Ayano Yokouchi1, Sae Asayama1, Yuki Inoue1, Koji Tomita1, Noriyuki Maeda1, Naoto Oku3, Tomohiro Asai2 (1. Nippon Fine Chemical Co., Ltd., 2. Univ. Shizuoka, Sch. Pharm. Sci., 3. Fac. of Pharma-Science, Teikyo Univ.)
[26PO10-am1-06S]Development of novel dendrimer-conjugate antibody for exosome-associated drug delivery system
○Kuon Kanazawa1, Shota Oyama1, Manami Urata1, Yu Mikame1, Tsuyoshi Yamamoto1, Asako Yamayoshi1 (1. Grad. Sch. Biomed. Sci., Nagasaki Univ.)
[26PO10-am1-07S]Development of functionalized DNA containing i-motifs that induces sustained immunoactivity of CpG DNA
○Wakana Oda1, Keisuke Umemura1, Koichi Ito1, Yuki Takahashi1, Yoshinobu Takakura1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
[26PO10-am1-08S]Analysis of the correlation between the shape of DNA nanotubes and cellular uptake selectivity.
○Kento Yasui1, Koichi Ito1, Yuki Takahashi1, Yoshinobu Takakura1 (1. Grad. Sch. Pharm. Sci., Kyoto Univ.)
[26PO10-am1-09]Effect of excipients on the in vitro permeability of Diclofenac Sodium Tape
○Yasuhiro Abe1, Akiko Usui1, Hiroyuki Yoshida1, Ken-ichi Izutsu1 (1. NIHS)
[26PO10-am1-10]Study on application of transmission Raman spectroscopy in content uniformity test
○Tatsuo Koide1, Toshiro Fukami2, Kenich Izutsu1 (1. Natl. Inst. Health Sci., 2. Meiji Pharm. Univ.)
[26PO10-am1-11]The Detection of Pyrogen by the Monocyte-Activation Test using Donated Blood in Japan
○Katsuhiko Hayashi1, Mizuki Sano2, Toshie Kanayasu-Toyoda1,3, Yuji Morita2, Yukiko Hara-Kudo1 (1. NIHS, 2. Meiji Pharm. Univ., 3. Nihon. Pharm. Univ.)
[26PO10-am1-12S]A comparative study on the pharmaceutical properties of switch OTC and prescription drugs [V]: Ufenamate cream
○Takako Sakata1, Yuko Wada1, Fumiyoshi Ishii1, Ken-ichi Shimokawa1 (1. Meiji Pharm. Univ.)
[26PO10-am1-13S]A comparative study on the pharmaceutical properties of switch OTC and prescription drug (VI): prednisolone valerate acetate cream
○Yui Miyajima1, Yuko Wada1, Fumiyoshi Ishii1, Ken-ichi Shimokawa1 (1. Meiji Pharm.Univ)
[26PO10-am1-14]Antiviral effect of electrolyzed reduced water on SARS-CoV-2
○Yuko Imanaka1, Yoshinao Okajima2, Masahiro Okajima2, Mitsuo Ikeda2, Ken-ichi Shimokawa1, Fumiyoshi Ishii1 (1. Meiji Pharmaceutical Univ., 2. A. I. System Products Corp.)
[26PO10-am1-15]Improvement of solubility of methoxysalicylic acid by cyclodextrin and evaluation of tyrosinase inhibitory activity
○Hideko Maeda1, Haruka Murokawa1, Mana Minamihira1, Masafumi Tanaka1, Akihiko Kajinami2, Hirokazu Nakayama1 (1. Kobe Pharm. Univ., 2. Grad. Sch. Eng., Kobe Univ.)
[26PO10-am1-16S]Concentration changes of insulins in the preparations with fibrotic insulins
○Momoka Suzuki1, Takahiro Suzuki1, Yui Ohno1, Yu Kojima1, Tomohiro Seki1, Toshinobu Seki1 (1. Laboratory of Pharmaceutics, Faculty of Pharmacy and Pharmaceutical Sciences, Josai University )
[26PO10-am1-17]Effect of electron beam irradiation on microbiological quality of pills formulated in-house and that on indicator ingredients in crude drugs
○Rumi Yamaoki1, Yuka Samizo1, Momoe Shimizu1, Naoya Kondo1, Takashi Temma1 (1. Osaka Medical and Pharmaceutical University)
[26PO10-am1-18]Appropriateness of using adult data on the acceptability of simple suspension in the pediatric field
○Katsuhiro Iwanishi1, Yumiko Otsu1, Chie Mochizuki1 (1. Osaka Women's and Chidren's Hospital)
[26PO10-am1-19S]The influence that laxative gives to pH of Levodopa
- Experiments carried out during practical training -
○Minami Sakai1, Misato Yamaoka2, Takahiro Hayashi1, Ikuto Tsukiyama2, Sadamasa Mase3 (1. Col. Pharm., Kinjo Gakuin Univ., 2. Col. Pharm., Meijo Univ., 3. Mase Pharm.)
[26PO10-am1-20S]A Study on Dosing Method to Improve Dissolution of Mesalazine -Experiment 2 during Practical Training-
○Niwa Miduki1, Machika Ishigaki1, Sadamasa Mase2, Takahiro Hayashi1, Toru Maeda1 (1. Col.Pharm., Kinjo Gakuin Univ., 2. Mase Pharm.)